| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 21,258 | 10,985 | 115 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 21,258 | 10,985 | 115 | | | Operating Expenses | | Research Development | 29,003 | 34,760 | 25,346 | | Selling General and Administrative | 9,797 | 9,332 | 7,753 | | Non Recurring | 9,916 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (27,458) | (33,108) | (32,983) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,505 | 5,940 | 4,296 | | Earnings Before Interest And Taxes | (23,953) | (27,168) | (28,688) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (23,953) | (27,168) | (28,688) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (23,953) | (27,168) | (28,688) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (23,953) | (27,168) | (28,688) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($23,953) | ($27,168) | ($28,688) |
|
0.29% Nasdaq 
0.01 (0.67%) 
Income Statement
